OpenRouter | $113,000,000 | (May 27, 2026)
The Path | $14,300,000 | (May 27, 2026)
Quartermaster | $43,000,000 | (May 27, 2026)
Certified by Founder
Lodge
Lassen Therapeutics
start up
United States
- San Diego, California
- 21/12/2023
- Series B
- $85,000,000
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
- Industry Biotechnology Research
- Website https://lassentherapeutics.com/
- LinkedIn https://www.linkedin.com/company/lassen-therapeutics/
Clouted | $7,000,000 | (May 27, 2026)
ClearOps | $10,009,454 | (May 27, 2026)
Hardline | $2,000,000 | (May 27, 2026)
Squid | $6,000,000 | (May 27, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Dandelion Health | $14,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
shatterdome energy | $3,500,000 | (May 22, 2026)